What does CUSIP 282559103 represent in this 13F holders report?

CUSIP 282559103 is the security identifier for ETNB - 89bio, Inc. - Common stock, par value $0.001 per share used to aggregate holder disclosures.

How many institutions held ETNB - 89bio, Inc. - Common stock, par value $0.001 per share in Q1 2024?

147 institutional investors reported ETNB - 89bio, Inc. - Common stock, par value $0.001 per share for Q1 2024. Use the holders table for investor-level position and value details.

89bio, Inc. - Common stock, par value $0.001 per share (ETNB)

CUSIP: 282559103

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class: Equity / Common stock, par value $0.001 per share
Shares outstanding: 148,275,293
Total 13F shares: 98,362,601
Share change: +4,237,929
Total reported value: $1,144,204,045
Put/Call ratio: 201%
Price per share: $11.64
Number of holders: 147
Value change: +$51,039,250
Number of buys: 90
Number of sells: 75

Quarterly Holders Quick Answers

What is CUSIP 282559103?
CUSIP 282559103 identifies ETNB - 89bio, Inc. - Common stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2024
Previous quarter: Q4 2023

Recent filing periods for CUSIP 282559103:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of ETNB - 89bio, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RA CAPITAL MANAGEMENT, L.P.	13F	Company	7.7%	11,416,948	$127,527,309	—	31 Dec 2023	13F
JANUS HENDERSON GROUP PLC	13F	Company	6%	8,915,141	$99,570,081	—	31 Dec 2023	13F
RTW INVESTMENTS, LP	13F	Company	3.8%	5,578,931	$62,316,659	—	31 Dec 2023	13F
BlackRock Finance, Inc.	13F	Company	3.7%	5,454,196	$60,923,368	—	31 Dec 2023	13F
STATE STREET CORP	13F	Company	3.6%	5,399,358	$60,310,829	—	31 Dec 2023	13F
SUVRETTA CAPITAL MANAGEMENT, LLC	13F	Company	3.3%	4,888,434	$54,603,808	—	31 Dec 2023	13F
Pictet Asset Management Holding SA	13F	Company	3.1%	4,557,680	$50,909,286	—	31 Dec 2023	13F
VANGUARD GROUP INC	13F	Company	2.9%	4,307,585	$48,115,725	—	31 Dec 2023	13F
BVF INC/IL	13F	Company	2.7%	4,047,354	$45,208,944	—	31 Dec 2023	13F
Holocene Advisors, LP	13F	Company	2.4%	3,490,628	$38,990,315	—	31 Dec 2023	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	2.1%	3,125,000	$34,906,250	—	31 Dec 2023	13F
Laurion Capital Management LP	13F	Company	1.8%	2,704,202	$30,205,936	—	31 Dec 2023	13F
CITADEL ADVISORS LLC	13F	Company	1.5%	2,178,339	$24,332,046	—	31 Dec 2023	13F
Frazier Life Sciences Management, L.P.	13F	Company	1.3%	2,000,000	$22,340,000	—	31 Dec 2023	13F
Redmile Group, LLC	13F	Company	1.3%	1,969,402	$21,998,220	—	31 Dec 2023	13F
FEDERATED HERMES, INC.	13F	Company	1.3%	1,962,566	$21,921,862	—	31 Dec 2023	13F
ORBIMED ADVISORS LLC	3/4/5	10%+ Owner	— class O/S missing	1,829,436	$21,093,397	—	25 Jan 2022	3/4/5
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	1.2%	1,761,148	$19,672,023	—	31 Dec 2023	13F
MORGAN STANLEY	13F	Company	1%	1,489,260	$16,635,038	—	31 Dec 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.93%	1,377,710	$15,390,799	—	31 Dec 2023	13F
SUPERSTRING CAPITAL MANAGEMENT LP	13F	Company	0.69%	1,021,477	$11,409,898	—	31 Dec 2023	13F
FRANKLIN RESOURCES INC	13F	Company	0.56%	827,703	$9,245,442	—	31 Dec 2023	13F
Orchard Capital Management, LLC	13F	Company	0.5%	739,208	$8,256,953	—	31 Dec 2023	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.47%	702,095	$7,842,401	—	31 Dec 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.43%	631,112	$7,049,521	—	31 Dec 2023	13F
NORTHERN TRUST CORP	13F	Company	0.42%	618,001	$6,903,071	—	31 Dec 2023	13F
Alyeska Investment Group, L.P.	13F	Company	0.39%	583,187	$6,514,199	—	31 Dec 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.38%	558,885	$6,242,745	—	31 Dec 2023	13F
MARSHALL WACE, LLP	13F	Company	0.37%	554,337	$6,191,945	—	31 Dec 2023	13F
BARCLAYS PLC	13F	Company	0.37%	543,552	$6,071,476	—	31 Dec 2023	13F
Erste Asset Management GmbH	13F	Company	0.34%	503,000	$5,636,020	—	31 Dec 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.34%	499,353	$5,577,773	—	31 Dec 2023	13F
Rafferty Asset Management, LLC	13F	Company	0.31%	453,674	$5,067,539	—	31 Dec 2023	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.28%	408,674	$4,564,889	—	31 Dec 2023	13F
STEMPOINT CAPITAL LP	13F	Company	0.28%	408,257	$4,560,231	—	31 Dec 2023	13F
Qube Research & Technologies Ltd	13F	Company	0.27%	403,324	$4,505,129	—	31 Dec 2023	13F
DEUTSCHE BANK AG\	13F	Company	0.26%	378,840	$4,231,643	—	31 Dec 2023	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.2%	298,989	$3,339,707	—	31 Dec 2023	13F
UBS Group AG	13F	Company	0.19%	284,497	$3,177,831	—	31 Dec 2023	13F
S.c.a. Candriam	13F	Individual	0.19%	280,000	$3,127,742	—	31 Dec 2023	13F
Newtyn Management, LLC	13F	Company	0.18%	272,500	$3,043,825	—	31 Dec 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.18%	271,899	$3,037,112	—	31 Dec 2023	13F
Caption Management, LLC	13F	Company	0.18%	260,000	$2,904,200	—	31 Dec 2023	13F
ROYAL BANK OF CANADA	13F	Company	0.17%	248,931	$2,781,000	—	31 Dec 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.16%	242,389	$2,707,486	—	31 Dec 2023	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.16%	239,027	$2,669,932	—	31 Dec 2023	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	0.16%	230,000	$2,569,000	—	31 Dec 2023	13F
Bank of New York Mellon Corp	13F	Company	0.15%	222,420	$2,484,432	—	31 Dec 2023	13F
Parkman Healthcare Partners LLC	13F	Company	0.15%	219,448	$2,451,234	—	31 Dec 2023	13F
CITIGROUP INC	13F	Company	0.14%	214,602	$2,397,104	—	31 Dec 2023	13F

Institutional Holders of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB) as of Q1 2024

As of 31 Mar 2024, 89bio, Inc. - Common stock, par value $0.001 per share (ETNB) was held by 147 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 98,362,601 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., JANUS HENDERSON GROUP PLC, RTW INVESTMENTS, LP, BlackRock Inc., SUVRETTA CAPITAL MANAGEMENT, LLC, STATE STREET CORP, VANGUARD GROUP INC, BVF INC/IL, PICTET ASSET MANAGEMENT Holding SA, and Holocene Advisors, LP. This page lists 147 institutional shareholders reporting positions in this security for the Q1 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders

152

Q1 2024 holders

147

Holder diff

-5

Investor	Q4 2023 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q4 2023 Value $	Q1 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.